Date: September 28, 2023
Attention: All Providers
Call to action: Vendor Drug Program (VDP) announced the 2023-34 RSV season in a notice published to TexConnect on September 21, 2023. HHSC has since revised Form 1321 to address using the new product, Beyfortus, during the season.
UPDATE: Health and Human Services (HHSC) revised the Synagis Standard Prior Authorization Addendum (HHS Form 1321) to reflect Beyfortus use.
How this impacts providers:Here is a link to the 1321 form.
Next step for Providers: Providers should utilize the new prior authorization form.
If you have any questions, please email Provider Relations at: providerrelations@texaschildrens.org.
For access to all provider alerts,log into:
www.thecheckup.org or www.texaschildrenshealthplan.org/for-providers.